- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: programmed cell death-ligand 2 (PD-L2, PDL2)
Total 94280 results
-
Peking University Cancer Hospital & InstituteRecruitingColorectal Cancer | Lung CancerChina
-
Merck Sharp & Dohme LLCActive, not recruitingBreast NeoplasmsKorea, Republic of, Germany, United States, United Kingdom, Argentina, Australia, Austria, Brazil, Canada, Chile, China, Colombia, France, Greece, Guatemala, Hungary, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, Phili... and more
-
Kyowa Kirin Co., Ltd.Kyowa Hakko Kirin Pharma, Inc.CompletedIdiopathic Parkinson's DiseaseUnited States, Canada, Czechia, Germany, Israel, Italy, Poland, Serbia
-
Makassed General HospitalRecruitingReduce Pain After HerniorrhaphyLebanon
-
Merck Sharp & Dohme LLCEisai Inc.Active, not recruitingGlioblastoma | Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Ovarian Cancer | Advanced Solid Tumors | Triple Negative Breast Cancer | Biliary Tract CancersUnited States, Argentina, Australia, Canada, Chile, Colombia, France, Germany, Israel, Italy, Korea, Republic of, Russian Federation, Spain, Switzerland, Taiwan, Thailand, United Kingdom
-
Diwakar DavarImmunocore LtdNot yet recruitingUveal MelanomaUnited States
-
The University of Hong KongCompletedType 2 Diabetes | KetonemiaHong Kong
-
China Meitan General HospitalMarino Biotechnology Co., Ltd.UnknownRecurrent PD-L1+ Malignant Tumors | Metastatic PD-L1+ Malignant TumorsChina
-
Curis, Inc.CompletedAdvanced Solid Tumors or LymphomasUnited States, Spain, Korea, Republic of, United Kingdom
-
National Cancer Institute (NCI)Active, not recruitingHematopoietic and Lymphoid Cell Neoplasm | Advanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory Lymphoma | Refractory Malignant Solid NeoplasmUnited States
-
23andMe, Inc.Michael J. Fox Foundation for Parkinson's Research; The Parkinson's InstituteCompleted
-
Charitable Union for the Research and Education...Active, not recruitingVasectomy ReversalUnited States
-
Baylor Research InstituteCompleted
-
University of Cape TownCompletedEpilepsy | Children | Sedation | ElectroencephalogramSouth Africa
-
Shanghai International Medical CenterUnknownAdvanced Solid Tumor | PD-1 Antibody | CAR-T CellsChina
-
Second Affiliated Hospital of Soochow UniversityNot yet recruiting
-
University Hospital, MontpellierFondation Jérôme Lejeune; association autour des Williams; réseau de santé Maladies...UnknownAnxiety | Williams SyndromeFrance
-
LEO PharmaCompletedPlaque Psoriasis | Psoriasis VulgarisGermany
-
AryoGen Pharmed Co.CompletedBioequivalence | Phase 1Iran, Islamic Republic of
-
CinnagenCompletedBioequivalence | Phase 1Iran, Islamic Republic of
-
Charite University, Berlin, GermanyCompletedActive Digital UlcersGermany
-
Well Living Lab, Inc.Mayo ClinicRecruitingPhysical Activity | Sleep | Cognitive Function | Social IsolationUnited States
-
University Hospital, MontpellierCompletedPatients Recieving Anti-PD-1 or Anti-PD-L1 ImmunotherapiesFrance
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Childhood Ependymoma | Advanced Malignant Solid Neoplasm | Recurrent Ewing Sarcoma | Recurrent Hepatoblastoma | Recurrent Langerhans Cell Histiocytosis | Recurrent Malignant Germ Cell Tumor | Recurrent Malignant Glioma | Recurrent Medulloblastoma | Recurrent Neuroblastoma | Recurrent Non-Hodgkin... and other conditionsUnited States, Puerto Rico
-
RenJi HospitalRecruitingUpper Urinary Tract Urothelial Carcinoma | Kidney Preservation | HER-2 ADC | PD-1antibodyChina
-
Samsung Medical CenterUnknown
-
Merck Sharp & Dohme LLCRecruitingAdvanced Solid Tumors | Metastatic Solid TumorsCanada, Switzerland, United States
-
Giovanni MirabellaCompleted
-
Wuxi People's HospitalRecruitingCancer | PD-L1 Gene MutationChina
-
DePuy SpineCompletedDegenerative Disc DiseaseUnited States
-
Chiron CorporationUnknownHIV InfectionsUnited States
-
Genzyme, a Sanofi CompanyDiacrin/Genzyme Corporation LLCCompleted
-
Ningbo Cancer HospitalUnknownAdvanced Malignancies | PD-1 Antibody | CAR-T CellsChina
-
Jiangsu vcare pharmaceutical technology co., LTDCompletedHealthy Subjects | PK/PDChina
-
Instituto Nacional de Cancer, BrazilCompletedTriple Negative Breast Cancer | Triple Negative Breast NeoplasmsBrazil
-
Luzerner KantonsspitalNot yet recruitingPain, Postoperative | IVFSwitzerland
-
University of PittsburghCompletedTotal Hip ArthroplastyUnited States
-
Centro Cardiologico MonzinoIRCCS Policlinico S. DonatoRecruitingCardiovascular Diseases | Coronary Artery Disease | MigraineItaly
-
Regeneron PharmaceuticalsTerminatedAdvanced PD-L1 Positive MalignanciesUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)WithdrawnRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal CarcinomaUnited States
-
Istituto Oncologico Veneto IRCCSJanssen Diagnostics, LLCUnknownMetastatic MelanomaItaly
-
Guohui LiRecruitingPD-1 | Immune Related Adverse EventsChina
-
University Medical Center GroningenActive, not recruitingLocally Advanced or Metastatic Solid Tumors Irrespective of PD-L1 ExpressionNetherlands
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Mantle Cell LymphomaUnited States
-
Radboud University Medical CenterZonMw: The Netherlands Organisation for Health Research and Development; Dutch...CompletedHematological MalignanciesNetherlands
-
Inge Marie SvaneCompletedPolycythemia Vera | Essential ThrombocythemiaDenmark
-
University of MinnesotaChildren's Cancer Research Fund United StatesTerminatedLymphoblastic Lymphoma | Brain Tumors | Lymphoblastic Leukemia, Acute, Childhood | Lymphoblastic Leukemia | Leukemia, Lymphocytic, Acute | Leukemia, Lymphoblastic, Acute | Brain Neoplasms, Malignant | ALL, Childhood | Leukemia, Lymphoblastic, Acute, Philadelphia-Positive | Lymphoblastic Leukemia, Acute | Leukemia... and other conditionsUnited States
-
The Second Affiliated Hospital of Harbin Medical...UnknownContract Management PD
-
Hoffmann-La RocheCompletedLymphocytic Leukemia, ChronicGermany
-
Gruppo Italiano Malattie EMatologiche dell'AdultoCompletedPatients With CLL Relapsing After an Initial Response (CR, PR ≥ 6 Months) Following no More Than Two Prior Treatment Lines; or | Patients With CLL Refractory (SD, PD or CR/PR < 6 Months) Following no More Than Two Prior Treatment LinesItaly